Q4 2025 Management View CEO Lawrence Bruno highlighted that "Core continued to execute its strategic plan of technology ...

This morning, I am joined by Christopher Scott Hill, Core's Chief Financial Officer, and Gwendolyn Y. Gresham, Core's Senior ...

Core Laboratories (CLB) came out with quarterly earnings of $0.21 per share, beating the Zacks Consensus Estimate of $0.2 per ...

CEO Lawrence V. Bruno highlighted that "Core continued to execute its strategic plan of technology investments targeted to both solve client problems and capitalize on Core's technical and geographic ...

Reports Q1 revenue $123.6M, consensus $124.8M. Core’s CEO, Larry Bruno stated, “In addition to the normal seasonal decline in client activity that typically occurs between the fourth and first ...

(1) Three months ended September 30, 2024 includes reversals of stock compensation expense previously recognized due to a change in probability of performance condition for certain executive's share ...

(1) The year ended December 31, 2023 includes reversals of stock compensation expense previously recognized due to a change in probability of performance condition for certain executive's share awards ...

Wide-moat Core Laboratories posted third-quarter results mostly in line with our estimates. Revenue of $134 million was up 3% sequentially and 7% year over year, while operating income of $20 million ...

Core Laboratories is in good financial health. At the last reporting period, the firm had $16 million of cash on hand and $180 million of long-term debt. 2022 net debt/adjusted EBITDA was elevated at ...

(2) Includes the write-down of leasehold improvements, right of use assets and/or other assets and exit costs associated with consolidation of certain facilities. (3) Includes gain on insurance ...